Reference #: 2017-042
This invention provides an ultrasensitive assay for GFAP and other biomarkers of TBI to
accurately detect or measure biomarkers of mild, moderate and severe TBI. Further, it provides a
means to monitor or prevent sequelae of TBI, helping to triage and guide the treatment of TBI
afflicted individuals of varying severity.
Accurate methods for diagnosing, prognosing, monitoring recovery from and assessing traumatic brain injury (TBI)
The assay can be combined with APOE4+ allele screening for improved diagnosis, prognosis, and monitoring of recovery
Stage of Development